Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Patent
1984-12-26
1987-09-22
Brown, Johnnie R.
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
514825, 514863, 514866, 514885, A61K 3556
Patent
active
046954597
ABSTRACT:
Certain autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and systemic lupus erythematosus may be prevented or attenuated by in vivo treatment with a complement-fixing anti-Leu3 (CD4) antibody that is cytotoxic to Leu3 (CD4) phenotype T cells.
REFERENCES:
P. Y. Patterson in Autoimmunity, N. Talal, Ed. (Academic Press, NY, 1977), pp. 644-692.
B. G. Arnason, B. D. Jankovic, B. H. Waksman and C. Wennersten, J. Exp. Med., 116, 117 (1962).
N. K. Gonatas and J. C. Howard, Science, 186, 839 (1974).
L. Ortiz-Ortiz and W. O. Weigle, J. Exp. Med., 144, 604 (1976).
U. Traugott, E. L. Reinherz and C. S. Raine, Science, 219, 308 (1982).
C. B. Pettinelli and D. E. McFarlin, J. Immunol., 127, 1420 (1981).
Z. Lando and A. Ben-Nun, Clin. Immunol. & Immunopath., 290 (1984).
D. P. Dialynas et al, Immunol. Reviews, 74, 29 (1983).
E. L. Reinherz and S. F. Schlossman, N. Engl. J. Med., 303, 370 (1980).
E. L. Reinherz et al, N. Engl. J. Med., 303, 125 (1980).
P. Marrack et al, J. Exp. Med., 158, 1077 (1983).
S. P. Cobbold et al, Nature, 312 (1984).
S. W. Brostoff and D. W. Mason, J. Immunol., 133, 1938 (1984).
E. G. Engelman et al, Brief Definitive Report, 153 (1981), pp. 193-196.
G. Goldstein et al, D. H. Katz, Ed. (CRC Press, 1982), pp. 72-89.
M. K. Waldor et al, manuscript submitted to Science, estimated publication Jan. 1985.
Herzenberg Leonard A.
Herzenberg Leonore A.
Sriram Subramanian
Steinman Lawrence
Waldor Matthew K.
Brown Johnnie R.
Rollins John W.
The Board of Trustees of Leland Stanford Junior University
LandOfFree
Method of treating autoimmune diseases that are mediated by Leu3 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating autoimmune diseases that are mediated by Leu3, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating autoimmune diseases that are mediated by Leu3 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2057864